RLYB - Balance Sheet - Rallybio Corporation

Current Liabilities	6.24 M
Accounts Payable	278 K
Short-Term Debt	154 K
Other Current Liabilities	5.81 M
Non-Current Liabilities	212 K
Long-Term Debt	0
Other Non-Current Liabilities	212 K

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	13.9	24.5	57.0	175.3	140.2	19.5
Short Term Investments	51.6	85.4	112.0	0	0	0
Receivables	0	0	0	0	0	0
Inventory	0	0	0	0	0	0
Other Current Assets	1.0	4.9	20.0	10.7	2.1	2.9
Total Current Assets	67.8	114.8	179.5	180.9	141.3	20.9
PP&E	0.3	0.6	0.9	0.5	0.3	0.2
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	0	0.2	30 K	0.8	0.3	0.5
Other Long Term Assets	0	0	0	0	0	0
Other Assets	0	0	0	0	0	0
Total Assets	68.1	115.6	180.4	182.2	141.9	21.6
LIABILITIES
Accounts Payable	0.3	1.0	1.1	0.6	1.6	0.9
Short Term Debt	0.2	0.2	0.4	0	0	0
Other Current Liabilities	5.0	8.1	9.3	5.9	4.3	2.9
Total Current Liabilities	6.2	9.3	10.7	6.6	5.8	3.8
Long Term Debt	0	0.2	0.7	0	0	0
Deferred Tax Income	0	0	0	0	0	0
Other Liabilities	0	0	(0.4)	32 K	182.0	38.1
Total Liabilities	6.5	9.4	11.1	6.6	187.9	41.9
EQUITY
Common Stock	4 K	4 K	4 K	3 K	1.0	0.3
Retained Earnings	(293.0)	(235.2)	(160.7)	(94.0)	(47.0)	(20.6)
Other Accumulative Comprehensive Income/Loss	0	15 K	(0.2)	0	(230.0)	(58.0)
Total Equity	61.7	106.2	169.3	175.6	(47.0)	(20.6)
Total Liabilities and Equity	68.1	115.6	180.4	182.2	187.9	41.9
SHARES OUTSTANDING
Common Shares Outstanding	43.5	40.4	31.8	32.1	32.1	32.1

Free